ArticleAMB Express2025
Marine-derived phlorotannins: sustainable inhibitors of multiple virulence factors in Pseudomonas aeruginosa.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Controlling Staphylococcus aureus skin infections by targeting biofilm and virulence properties using FDA-approved antiseptics and skin care products.Folia microbiologica · 2026Article
- Phlorotannins and glycolipid metabolism: comprehensive regulatory roles mediated by the gut microbiota.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pseudomonas aeruginosa is a highly adaptable opportunistic pathogen in diverse environments, causing plant, animal, and human infections. Its remarkable ability to resist antibiotics and deploy multiple virulence strategies is attributed to its large genome, horizontal gene transfer, and complex regulatory networks. In this study, we comprehensively investigated 15 structurally distinct phlorotannins against 18 major virulence-associated proteins, such as quorum-sensing proteins, adhesion proteins, exotoxins, siderophore receptors, secretion system components, proteases, motility, and biofilm formation. Molecular docking and 50-ns molecular dynamics simulations revealed that compounds such as 2-phloroeckol, 7-phloroeckol, phlorofucofuroeckol A, and phlorofucofuroeckol B formed strong and stable interactions with critical targets, type IV pilus biogenesis factor PilY1, ferripyoverdine receptor, and phenazine-1-carboxylate-methyltransferase, with binding free energies as low as - 12.24 kcal/mol. These compounds exhibited a wide range of non-covalent interactions, including hydrogen bonding and π-π stacking, with essential active site residues in target proteins. Drug-likeness and environmental safety assessments utilizing the pkCSM and VEGA (Q)SAR models revealed high oral bioavailability, low toxicity, minimal cytochrome P450 interactions, and mostly non-mutagenic profiles. This study reveals phlorotannins as prospective eco-friendly alternatives for reducing P. aeruginosa infection by addressing a broad spectrum of virulence factors with ecologically benign and biodegradable natural compounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.